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Background/aim: The purpose of the present study was to determine the distribution and epidemiological features of mycobacteria
with molecular methods.
Materials and methods: Fifty-five culture-positive samples were analyzed by polymerase chain reaction-restriction enzyme length
polymorphism (PCR-RFLP) at species level, and their molecular typing was performed with spoligotyping. The IS6110 region and the
locus of gene coding for Hsp65 were amplified. RFLP profiles were obtained by cutting the Hsp65 region with the Hae III and BstE II
(Eco91I) enzymes. Spoligotyping was carried out by commercial kit. The H37Rv strain was used as the control.
Results: All samples showed the same cutting pattern with the H37Rv strain. The RFLP profiles of 9 strains identified as “mycobacteria
other than tuberculosis” were compatible with the M. tuberculosis complex. Spoligotyping of 55 isolates detected 13 different genetic
profiles. The Beijing genotype was not detected. One isolate was described as an orphan strain according to the SpolDB4 database. The
most frequently detected family was T1 with 32 strains (64%), followed by 9 isolates (18%) belonging to the LAM7 TUR family.
Conclusion: PCR-RFLP is a specific, rapid, and effective method in routine diagnosis of mycobacteria. Spoligotyping is an ideal method
in the determination of genotypic varieties of mycobacteria.
Key words: Mycobacterium tuberculosis, RFLP, spoligotyping

1. Introduction
Although tuberculosis is one of the oldest diseases in history,
it is still a serious public health problem. Tuberculosis ranks
first (25%) among the causes of preventable mortality
worldwide (1). Today there are more than 100 species
of mycobacteria other than tuberculosis (MOTT) in
the genus Mycobacterium besides the members of the
Mycobacterium tuberculosis complex (M. tuberculosis,
M. bovis, M. microti, and M. africanum). Identification of
the mycobacteria produced with various methods is an
essential stage in the diagnosis of infection. The rapid and
accurate identification of mycobacteria will allow both
taking measures against transmission and determining
appropriate treatment alternatives. Depending on the
increase in immune-suppressed cases and the developments
in diagnostic techniques, an increasing number, and more
and more species, of MOTT bacteria are isolated as disease
agents every passing day (2). Since conventional methods
take a long time, molecular methods were put into use as
supplementary methods for quick diagnosis (3).
* Correspondence: fahriyeeksi@hotmail.com
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The phylogenetic features of M. tuberculosis and its
dynamics of spreading became more comprehensible
upon the development of molecular techniques. The
recurrence of tuberculosis, whether a secondary infection
is a reinfection or reactivation, and the simultaneous
presence of infections by two or more strains in a patient
can be revealed through molecular typing. In this way,
the efficiency of tuberculosis control and treatment
protocols can be investigated. Great benefits are obtained
in the investigation of epidemics and the identification of
intralaboratory cross-transmission. With these methods,
the transmission within a specific geographical area can
be analyzed and the exogenous superinfections in patients
with either a complete or an inadequate immune system can
be determined. It can be revealed that there are infections
by different strains in relapsing patients. The origin of
multiple drug-resistant (MDR) strains and their ways of
spreading can be shown with the methods of molecular
typing. The typing of M. tuberculosis strains may provide
the answers to important epidemiological questions such
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as the origin of an infection in a community or a family,
its spreading, and early detection of those strains that
have acquired resistance. Molecular epidemiology helps
to monitor the distributions in the community of those
isolates that are considered more virulent (4–8).
To specify the differences among the slowly
reproducing Mycobacterium species, Plikaytis et al. (9) first
developed a method with PCR and RFLP analyses in 1992.
Later, Telenti et al. (10) investigated the genes that encoded
65-kDA heat-shock proteins by using PCR and restriction
enzyme analyses. The RFLP method is a technique that
can determine the single base mutations or the DNA
fragments in different sizes. It is based on the examination
of the DNA by dividing it into fragments in different
sizes with restriction endonucleases (RE). Spoligotyping
(spacer oligonucleotide typing) is a method of typing
that depends on the DNA polymorphism occurring in
a special chromosomal locus called ‘direct repeat (DR)’,
which is only found in M. tuberculosis complex bacteria
(11). The method is based on the amplification of the
DNA sequence of the highly polymorphic DR locus in
the chromosomes of the M. tuberculosis complex strains.
This locus was first identified by Hermans et al. (11), who
sequenced this region in the M. bovis BCG strain, which
is used in vaccination against tuberculosis worldwide. As
clinical isolates vary according to the presence or absence
of these spacer sequences, mycobacterial strains can be
differentiated by these different hybridization patterns or
spoligotypes (11).
In our study, we aimed to investigate the diversity of
genotypes and to type the strains in MDR tuberculosis
induced by M. tuberculosis strains with the RFLP and
spoligotyping methods.
2. Materials and methods
2.1. Culture-antibiotic sensitivity testing
To conduct this research, approval was obtained
(Resolution No. 03-2008/38) from the Ethics Committee at
Gaziantep University. Some 55 samples, sent from various
clinics of the Medical Faculty Hospital of Gaziantep
University, were investigated between January 2005 and
January 2007 in the present study. Identification of species
was performed by PCR-RFLP analysis, and the molecular
types were investigated by spoligotyping in the samples in
which acid-resistant bacillus (ARB) and growth in culture
were detected with the Ehrlich–Ziehl–Neelsen (EZN)
staining method. In this retrospective study, the samples
tested consisted of stock bacterial cultures and did not
directly involve any human subjects.
Of the samples, 47 (85.4%) were obtained from
patients followed up in the clinic of thoracic diseases, 3
(5.5%) from patients followed up in the clinic of thoracic
surgery, 3 (5.5%) from patients followed up in the clinic

of pediatrics, and 2 (3.6%) from patients followed up in
the clinic of general surgery; 16 of the patients (29.1%)
were female and 39 (70.9%) were male. A sample of each
patient was included in the research. The 55 samples sent
to our laboratory consisted of 48 (87.3%) sputum samples,
3 (5.5%) bronchoalveolar lavage samples, 1 (1.8%) gastric
lavage sample, 1 (1.8%) abscess material, 1 (1.8%) pleural
fluid sample, and 1 (1.8%) lymphatic gland biopsy sample.
After homogenization and decontamination with 3%–
4% NaOH and N-acetyl-L-cysteine, the samples were
cultured into the BACTEC 12B liquid medium. The ARBs
were investigated with EZN staining. Differentiation
between M. tuberculosis complex and nontuberculous
mycobacteria was achieved by selective inhibition of the M.
tuberculosis isolates in the presence of 5 mL/mL p-nitro-aacetylamino-b-hydroxypropiophenone (NAP) according
to the BACTEC manual. Drug susceptibility testing
against rifampicin (R), isoniazid (I), streptomycin (S), and
ethambutol (E) was performed by using the BACTEC 460TB according to the manufacturer’s instructions.
The samples included in the research were particularly
selected from patients with MDR tuberculosis.
Mycobacterium tuberculosis H37Rv (ATCC 27294) was
used as the control strain.
2.2. Isolation of the Mycobacterium DNA
The Chelex method was used for the extraction of
Mycobacterium DNA (12). During this procedure, the aim
was to protect the nucleic acids against disintegration, to
remove the amplification inhibitors from the medium,
and to purify and concentrate the target nucleic acid. The
samples were preserved at –70 °C in order to be used for
PCR.
2.3. Amplification of the IS6110 region specific to the M.
tuberculosis complex by PCR
Primers T4 and T5 of the IS6110 region specific to the M.
tuberculosis complex were used in the study (T4: 5’-CCT
GCG AGC GTA GGC GTC GG -3’, T5: 5’-CTC GTC CAG
CGC CGC TTC GG -3’). To amplify the DNA region, a
PCR mix, amounting to 45 µL in total (distilled water:
30.75 µL; PCR buffer (10X): 5 µL; MgCl2 (25 mM): 3 µL;
dNTP (10 mM): 1 µL; primer 1 (T4, 10 pmol/µL): 2.5 µL;
primer 2 (T5, 10 pmol/µL): 2.5 µL; and Taq polymerase
(5 U/µL): 0.25 µL) was prepared in a 1.5 mL Eppendorf
tube on ice; 5 µL of Mycobacterium DNA was added to it,
and the mixture placed into the thermal cycler. Following
the application of PCR at 94 °C for 5 min in a cycle in the
thermal cycler, they were kept at 94 °C for 1 min, at 60
°C for 1 min, and at 72 °C for 2 min in 35 cycles. Later,
they were kept at 72 °C for 8 min and the PCR products
were obtained. The samples were run in 1.5% agarose gel
at 125 V for 20 min. They were examined under a UV
transilluminator. The samples that had the expected bands
were considered positive.
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2.4. Amplification of the Hsp 65 region specific to all
Mycobacteria by PCR
To detect all mycobacteria, a classical PCR was performed
using Primers TB11: 5’-ACC AAC GAT GGT GTG TCC
AT-3’ and TB12: 5’-CTT GTC GAA CCG CAT ACC CT3’ belonging to the Hsp 65 region. A PCR mix containing
30.75 µL of distilled water, 5 µL of PCR buffer (10X), 3 µL of
MgCl2 (25 mM), 1 µL of dNTP (10 mM), 2.5 µL of primer
1 (TB11, 10 pmol/µL), 2.5 µL of primer 2 (TB12, 10 pmol/
µL), and 0.25 µL of Taq polymerase (5 U/µL) was prepared,
and 5 µL of the sample’s DNA was added to it. Following
the application of a cycle at 94 °C for 5 min in the thermal
cycler, 35 cycles were applied at 94 °C for 1 min, at 55 °C for
1 min, and at 72 °C for 2 min. The PCR was completed with
a cycle at 72 °C for 8 min. Bands were obtained by running
the products in 1.5% agarose gel. The samples that had the
expected bands were considered positive.
To determine the Mycobacterium species by cutting
the PCR product of the 65-kDa heat-shock protein region
specific to all Mycobacteria with the restriction enzymes,
the procedure described by Taylor et al. was applied
(13,14). The sequence amplified by the primers of the HSP
65 region was investigated in the agarose gel. By cutting 11
µL of each sample observed to have the appropriate band
(at the expected location and in adequate concentration)
with HaeIII (BsuRI) (distilled water: 2.0 µL; buffer R + : 1.5
µL; HaeIII: 0.5 µL (10 units/µL, Fermentas); PCR product:
11.0 µL; and total: 15.0 µL) and BstEII (Eco91I) (distilled
water: 2.0 µL; buffer O + : 1.5 µL; BstEII: 0.5 µL (10 units/
µL, Fermentas); PCR product: 11.0 µL; and total: 15.0 µL)
enzymes, the Mycobacterium species were identified. The
products cut by the restriction enzymes were run in 3%
NuSieve GTG agarose (FMC BioProduct). DNA Molecular
Weight Marker VIII (19–1114 bp) (Roche) was used as a
marker. The Mycobacterium species were identified by
evaluating the base sizes of the bands that appeared upon
the cutting of the PCR product according to the table
provided by Taylor and Telenti (10,14).
2.5. Spoligotyping
For the procedure of spoligotyping, studies were conducted
according to the instructions by the manufacturing
firm (Isogen Biosolutions Spoligotyping kit, Ocimum
Biosolutions Company, the Netherlands). Primers DRa
and DRb were used for amplification. DRa: 5’-ggT TTT
ggg TCT gAC gAC-3’ (marked with biotin at the 5’-end),
DRb: 5’-CCg AgA ggg gAC ggA AAC-3’. The PCR master
mix was prepared as follows: dH2O: 8.5 μL; DMSO: 1 μL;
master mix: 12.5 μL; DRa: 0.25 μL; DRb: 0.25 μL; and
DNA: 2.5 μL. The evaluation was made according to the
positivity of the spacers. Spoligotyping is expressed as a
word that comprises 43 letters. This alphabet contains 3
letters: positive, negative, and indefinite. The spoligotype
patterns were encoded in triplet codes, and the types were
identified (Figure 1).
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The obtained results were compared with the
international spoligotyping database, and the spoligotypes
were detected (15).
The distribution of spacers in the DR region is also
used in the differentiation of species (Figure 2).
2.6. Statistical analyses
SPSS for Windows, version 11.5, was used and P < 0.05
was considered significant.
3. Results
The 55 samples included in the study were obtained from
various clinics (Table 1). Attention was paid to the fact that
the samples were MDR tuberculosis agents. In the culture
and identification carried out previously, 46 samples had
been evaluated as M. tuberculosis complex and 9 samples
as MOTT.
3.1. Drug resistance
The susceptibility of MOTT bacteria to antituberculosis
drugs was not studied. Of the strains in the 46 samples,
18 (39%) were susceptible to all antituberculosis drugs,
whereas 11 (24%) were resistant to 1 drug, 11 (24%) to
2 drugs, 3 (6.5%) to 3 drugs (isoniazid, rifampicin, and
ethambutol), and 3 (6.5%) agents to 4 drugs. Resistance
patterns of the 28 drug-resistant isolates are shown in
Table 2.

Figure 1. Interpretation of the spoligotyping images (43 slots).
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Figure 2. Differentiation of the species with spoligotyping (16).
Table 1. Distribution of the samples according to the departments from which they were obtained.
Sputum
n (%)

Bronchoalveolar lavage
(BAL)
n (%)

Gastric lavage
(GL)
n (%)

Abscess
material
n (%)

Pleural fluid
n (%)

Lymphatic
gland
n (%)

Thoracic diseases

41 (85.4)

2 (66.7)

0 (0.0)

1 (100)

1 (100)

0 (0.0)

Thoracic surgery

2 (4.2)

1 (33.3)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100)

Pediatrics

2 (4.2)

0 (0.0)

1(100)

0 (0.0)

0 (0.0)

0 (0.0)

Other

3 (6.2)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Total

48 (100)

3 (100)

1 (100)

1 (100)

1 (100)

1 (100)

Table 2. Resistance patterns of the drug-resistant isolates.

Drugs

Number of the resistant isolates
n (%)

Streptomycin (S)

0 (0.0)

Isoniazid (I)

6 (21.4)

Rifampicin (R)

3 (10.7)

Ethambutol (E)

2 (7.1)

S+I

4 (14.3)

I+R

5 (17.9)

I+E

1 (3.6)

R+E

1 (3.6)

I+R+E

3 (10.7)

S+I+R+E

3 (10.7)

Total

28 (100)

3.2. PCR-RFLP
Following the isolation of all samples with the Chelex
method, the IS6110 DNA region specific to the M.
tuberculosis complex was multiplied with PCR using
Primers T4 and T5 (Figure 3). All of the 55 samples formed
a band. RFLP was performed following the multiplication
of the Hsp 65 region specific to all Mycobacteria with
PCR using Primers TB11 and TB12. H37Rv was used as
the control strain. Bands were detected by running the
cut products in 3% Nu-sieve agar. When the bands were
evaluated according to the molecular weight marker, all
of the 55 samples yielded the same RFLP images, and
the results were identical with those of the H37Rv strain
(Figure 4). The RFLP profiles of the 9 strains found to be
MOTT with the NAP test were also detected to be identical.
The samples cut by the BstEII and HaeIII enzymes were
evaluated in the algorithm (10,14) according to the band
sizes. All strains were congruent with the M. tuberculosis
complex.
3.3. Spoligotyping
Some 13 different genetic profiles were obtained in 55 M.
tuberculosis isolates by spoligotyping (Table 3). While 5
isolates formed a unique pattern, the remaining 50 isolates
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Figure 3. Images of the bands belonging to the 26 samples for the IS6110 DNA region specific to the M. tuberculosis
complex in agarose gel.

Figure 4. The RFLP profiles of the samples.

(90.9%) formed 8 clusters, with each of them containing
2 to 23 isolates. The Beijing genotype, determined to
be associated with multiple drug resistance, was not
encountered. Resistance of a total of 46 M. tuberculosis
complex isolates to antituberculosis drugs and their
familial characteristics are shown in Table 4. All of the 3
M. tuberculosis complex isolates resistant to all of the 4
antituberculosis drugs investigated in our study and 2 of
the isolates resistant to 3 drugs were detected to be in the
T1 family. No significant difference was found between the
resistance detected in the M. tuberculosis complex isolates
and the types of families (P = 0.983).
4. Discussion
Mycobacteria can lead to epidemics today as they have done
throughout history and appear as new epidemiological
types or drug-resistant microorganisms. According
to calculations by the World Health Organization, the
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number of newly infected people will reach 1 billion in
2020 unless efficient control measures are developed
(16,17). According to data from the Turkish Public Health
Institution of the Ministry of Health, about 13,000 to 14,000
new tuberculosis patients are recorded in Turkey annually.
In 2012, the total number of recorded tuberculosis cases
was 14,691 (18).
Unlike many other diseases affecting developing
countries, tuberculosis is a disease that can be controlled
and treated by taking efficient measures. In order to take
efficient control measures to prevent tuberculosis from
spreading, knowledge of the clonal relationship between
the isolates is required. The phylogenetic features of M.
tuberculosis and its dynamics of spreading became more
comprehensible with the development of molecular
techniques. The recurrence of tuberculosis, whether the
secondary infection is a reinfection or reactivation, and the
simultaneous presence of infections by two or more strains
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Table 3. The spoligotyping characteristics of the strains.
No.

Spoligotyping
(Octal encoding)

Number of strains
(n = 55)

%

Family

1

777777777760771

22

40

T1

2

777777737760771

5

9

T1

3

777777777560771

2

3.6

T1

4

777777677760771

1

1.8

T1

5

377777777760771

1

1.8

T1

6

777777777777771

1

1.8

T1

7

777777404760771

9

16.3

LAM 7 TUR

8

777777777773771

6

10.9

MANU 1

9

777777777763771

2

3.6

MANU 2

10

777777774020771

2

3.6

H1

11

777777777773771

2

3.6

H3

12

777777607760771

1

1.8

LAM 9

13

617777774020760

1

1.8

Orphan strain

Table 4. Resistance of 46 M. tuberculosis complex isolates to antituberculosis drugs and their familial characteristics.
SIRE

Total
n
%

RRRR
n
%

RRSS
n
%

SRRR
n
%

SRRS
n
%

SRSR
n
%

SRSS
n
%

SSRR
n
%

SSRS
n
%

SSSR
n
%

SSSS
n
%

H1

0
0

1
2.2

0
0

0
0

0
0

0
0

0
0

0
0

0
0

1
2.2

2
4.3

H3

0
0

1
2.2

0
0

0
0

0
0

0
0

0
0

0
0

0
0

1
2.2

2
4.3

LAM7 TUR

0
0

1
2.2

0
0

3
6.5

1
2.2

0
0

0
0

0
0

0
0

4
8.7

9
19.6

LAM9

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

1
2.2

1
2.2

MANU1

0
0

0
0

1
2.2

0
0

0
0

3
6.5

0
0

0
0

0
0

2
4.3

6
13

MANU2

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

1
2.2

1
2.2

T1

3
6.5

1
2.2

2
4.3

2
4.3

0
0

3
6.5

1
2.2

3
6.5

2
4.3

7
15.2

24
52.2

Orphan
strain

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

1
2.2

1
2.2

3
6.5

4
8.7

3
6.5

5
10.9

1
2.2

6
13.0

1
2.2

3
6.5

2
4.3

18
39.1

46
100

Family

Total
R: resistant, S: susceptible.
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used in the differentiation of the MOTT bacteria.
However, a mixed culture composed of the TB complex
and the MOTT bacillus can only show the presence of
the MOTT bacillus by causing an increase in the growth
index (GI). Furthermore, an erroneous increase in the
GI can be seen as a result of use of the substrate by the
contaminant in the event of contamination by bacteria
other than mycobacteria. In some studies it is stated that
the quantity of the inoculum is also essential (19,20). Thus,
it is recommended to verify the NAP test with nucleic
acid probes, chromatographic methods, or conventional
methods (1).
The Hsp 65 gene is also present in mycobacteria
other than the M. tuberculosis complex and displays
polymorphism among the mycobacterium species. The
identification of mycobacteria by investigating the Hsp65
gene with the RFLP method was first developed by Telenti
et al. (10) and this method has been used in applications
since 1993. Some 33 PCR-based restriction enzyme
pattern (PRA) samples were identified as original in the
study performed; 19 of them corresponded to single
species, while the remaining 14 of them were associated
with 5 species (M. flavescens, 2 types; M. chelonae, 2
subspecies; M. kansasii, 2 types; M. gordonae, 5 types;
and M. fortuitum, 3 subspecies) (10). Taylor et al. (14)
added 5 more PRA samples to the algorithm by Telenti (an
additional species and 4 new subtypes of the previously
identified species). Later Devallois et al. (21) further added
11 new PRA samples: 5 additional species and 6 subtypes
of the previously identified species. In our study, a
restriction enzyme analysis was conducted by multiplying
the 65-kDA heat-shock protein region with 439 base pairs
belonging to the 55 mycobacterium isolates produced in
the BACTEC tubes by the PCR, and BstEII and HaeIII
were used as enzymes. The isolates were run in 3% agarose
gel (NuSieve GTG agar), and the obtained band patterns
were evaluated. All patterns were found identical with
H37Rv (M. tuberculosis complex). In their studies in the
agarose gel, Brunello et al. (22) state that problems of
differentiation are experienced in the images of bands
below 100 bp and that there may be deviations of about 10
bp. Therefore, it is expressed that comparative studies with
10% PAGE will be appropriate. The evaluation of bands in
the agarose gel, a method first applied by Telenti et al. (10),
was later used by many researchers (14,21,23). Detection
of the real dimensions of the obtained base fragments is
rather difficult with the naked eye when devices (QIAxcel,
Qiagen) or computer programs (e.g., Pharmacia Biotech
ImageMaster VDS) developed to this end are unavailable.
The results are obtained by evaluating the recorded data
with computer programs, and safe reading is possible
from 6 bases to 1000 bases by means of the devices for
DNA sequence analysis (24). In laboratories where these
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devices and programs are unavailable, the result can be
obtained by using and comparing the standard strains
besides the DNA markers when determining the size
of fragments. In our study, the fragments obtained by
cutting with BstEII were evaluated as about 240, 120,
and 80 (±10) base pairs, and the fragments obtained
with the HaeIII enzyme were evaluated as 160, 140, and
70 (±10) base pairs. In the table created by Telenti et al.
(10), these values show the M. tuberculosis complex group
(10). The interpretation of the octal values obtained by
spoligotyping in our study also confirms that the isolates
belong to the M. tuberculosis complex group. In their study,
Brunello et al. (22) investigated the Hsp65 gene regions
of 54 Mycobacterium species with the RFLP method and
identified the Mycobacterium species by using 3% agarose
and 10% PAGE in order to determine the restriction
fragments. They stated in their study that the real sizes
of the fragments they had obtained with the PAGE-based
method provided the computation more precisely than the
agarose gel electrophoresis and that it was better than the
agarose gel electrophoresis in the understanding of species.
In their study on 47 M. tuberculosis complex isolates and 36
MOTT, Bahrmand et al. (25) expressed that species could
be differentiated more easily with this method and that it
might be employed in the rapid diagnosis of Mycobacterium
species in the clinical laboratory. On the other hand, in
a study by Varma-Basil et al. (26), it was stated that M.
tuberculosis was identified in the Hsp65 region in 84.5% of
the ARB-positive samples and in 11% of the ARB-negative
samples among the direct sputum samples of 226 patients
with the RFLP method. The researchers expressed that
when compared with preparations stained with the EZN
staining method, this method was more successful than all
conventional methods in the rapid direct detection of M.
tuberculosis from the samples despite its low susceptibility
(76.6%, 149/167) (26).
The method of spoligotyping is based on the DNA
sequence amplification of the highly polymorphic DR locus
in the chromosomes of M. tuberculosis complex strains,
and 43 clinical samples can be studied in one go (6,27).
In our study, 13 different genetic profiles were obtained
in 55 M. tuberculosis isolates with spoligotyping. While 5
isolates formed a unique pattern, the remaining 50 (90.9%)
isolates formed 8 clusters, with each of them containing 2
to 23 isolates. It was determined that one of the isolates
(1.8%) was an orphan strain that was not congruent with
any clusters known as a result of the comparison with
the strains in the SpolDB4 database. It was seen that the
most prevalent family among the strains included in the
study was the T1 family with 32 isolates (64%), followed
by the LAM7 TUR family with 9 isolates (18%). In a study
performed for a dissertation, the 450 M. tuberculosis strains
isolated from Malatya and the Marmara, Mediterranean,
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and Aegean regions were typed with the IS6110 RFLP and
spoligotyping methods, and 47 clusters (85.3%), including
384 strains and 66 unique (14.7%) profiles, were obtained
with spoligotyping (28). In the same study, 49 (10.9%)
orphan strains that did not match any strain were detected
and it was stated that the T-superfamily and families LAM
and Haarlem were the most prevalent families (28). In
addition, Otkun et al. (29) found 41 different patterns
(44.5%) in the 92 isoniazid- and rifampicin-resistant M.
tuberculosis isolates they collected from seven regions of
Turkey, and stated that the patterns of 3 spoligotyping
families (18.5%, T; 16.3%, LAM; and 5.4%, Haarlem) out
of them represented 40.2% of the isolates. They expressed
that they thought the spoligotyping patterns of the isolates
resembled the distribution of European origins, that MDR
isolates originated from different sources, and that drug
resistance developed independently in different patients
for such reasons as treatment insufficiencies (29).
In a spoligotyping study with 71 isoniazid-resistant
isolates in Poland by Augustynowicz-Kopec et al. (30), it
was stated that about 80% of the isolates belonged to either
the T-family or the Haarlem family. In the spoligotyping
in 3319 isolates collected from various countries in the
continents of Europe, America, Africa, and Asia it was
indicated that 259 clusters were formed and that 540
orphan spoligotypes were obtained. It was stressed that
18% of the isolates were of the Beijing type and that the
common types varied by continent (31). The culture and
spoligotyping susceptibility and specificity of 350 ARBpositive samples were investigated in a study with a total of
107 samples (64 ARB-positive and 43 ARB-negative) and
it was determined that the susceptibility and specificity
of the spoligotyping method were 98.2% and 95.5%,
respectively (32). In the same study, the susceptibility of
the cultures in the liquid medium was provided as 91.4%
and their specificity as 97.7% (32).
In a study performed in Bulgaria in 2008, the
genotypes of 113 M. tuberculosis isolates were examined
with the methods of spoligotyping and MIRU-VNTR;
15 spoligotyping clusters containing 2 to 29 strains and 5
unique isolates were identified; and it was stated that the
largest cluster (25.7%) belonged to the T1 family and that
the LAM7TUR family ranked second (5.4%) (33). Having
attributed their finding of the prevalence of LAM7TUR
above the world averages to the country’s location as
a neighbor of Turkey, the researchers highlighted the
importance of migrations in the spreading of the M.
tuberculosis genotypes (33).

In our study, it was established that 3 isolates resistant to
4 drugs (SIRE) (3/32, 9.4%) and 2 of the isolates resistant to 3
drugs (2/32, 6.3%) belonged to the T1 family. Nevertheless,
no significant difference was found between the resistant
strains detected in the M. tuberculosis complex isolates
and the family types (P = 0.983). However, the Beijing
genotype, determined to be associated with multiple drug
resistance, was not encountered in our study. The Beijing
genotype of M. tuberculosis has been observed to be highly
prevalent in the northwestern federal region of Russia (34).
According to a study conducted by Velayati et al. (35) in
Iran, the major M. tuberculosis superfamilies were found
to be African-Indian (24%), central Asian (20.8%), T clade
(20.7%), Haarlem I (4.4%), and Beijing (3.2%).
There is a limited number of studies on the typing of
mycobacteria with the method of spoligotyping in Turkey.
It is seen in these studies that the common genotype in
Turkey is the T1 family (36,37). Bulut et al. (36) obtained
15 different genotype patterns in the spoligotyping of 48
primary drug-resistant isolates they had isolated from the
Kelkit Valley and failed to type 4 isolates. In that study,
they stated that the most prevalent spoligotype families
were TI (37.5%), S (25%), and LAM-7 TUR (8.3%) (36).
Moreover, in a study performed in Adana region, it was
stated that, depending on the method of spoligotyping,
443 (94.9%) of 467 isolates formed 21 clusters, 24 isolates
could not be typed, and the most prevalent family was the
T1 family with 239 isolates (51.9%), followed by the LAM7
TUR family with 54 isolates (11.5%) (37).
In conclusion, the PCR-RFLP analysis is a specific, quick,
and effective method for the identification of species and
can be used in the routine identification of mycobacteria. It
is seen that the method has potential for quicker and more
accurate identification than the conventional methods of
identification based on the morphological and biochemical
properties of mycobacterial isolates. The quick diagnosis
of the disease will allow the early initiation of treatment
by clinicians, and therefore a decrease in morbidity and
mortality. Spoligotyping is an ideal method of determining
the diversity of genotypes of mycobacteria, typing them,
and conducting epidemiological studies. Thus, the
obtained information will be beneficial for the accurate
planning of treatments for MDR tuberculosis patients in
Turkey and for the prevention of their infectivity.
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